These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11361596)

  • 21. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone in the management of agitation in HIV dementia.
    Lodge P; Tanner M; McKeogh MM
    Palliat Med; 1998 May; 12(3):206-7. PubMed ID: 9743841
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.
    Fossey J; Ballard C; Juszczak E; James I; Alder N; Jacoby R; Howard R
    BMJ; 2006 Apr; 332(7544):756-61. PubMed ID: 16543297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risperidone: a real alternative for patients treated with depot neuroleptics].
    Bobes J; González MP; Sáiz PA; Octavio I; Fernández JM; Bousoño M
    Actas Esp Psiquiatr; 2000; 28(6):367-72. PubMed ID: 11262281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update.
    DeVane CL; Mintzer J
    Psychopharmacol Bull; 2003; 37(4):116-32. PubMed ID: 15131522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risperidone treatment of behavioral disturbances in outpatients with dementia.
    Irizarry MC; Ghaemi SN; Lee-Cherry ER; Gomez-Isla T; Binetti G; Hyman BT; Growdon JH
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):336-42. PubMed ID: 10440009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances.
    Frenchman IB; Prince T
    Int Psychogeriatr; 1997 Dec; 9(4):431-5. PubMed ID: 9549592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics.
    Kleijer BC; van Marum RJ; Egberts AC; Jansen PA; Frijters D; Heerdink ER; Ribbe M
    Int Psychogeriatr; 2009 Oct; 21(5):931-40. PubMed ID: 19538831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic treatment of agitation and psychosis in dementia.
    Devanand DP; Levy SR
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S18-27. PubMed ID: 8561840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone for control of agitation in dementia patients.
    Falsetti AE
    Am J Health Syst Pharm; 2000 May; 57(9):862-70. PubMed ID: 10840527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of risperidone in psychotic disorder following ischemic brain damage.
    Zimnitzky BM; DeMaso DR; Steingard RJ
    J Child Adolesc Psychopharmacol; 1996; 6(1):75-8. PubMed ID: 9231301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIDS dementia complex and Hashimoto encephalopathy in a senescent woman.
    Waltereit R; Schulte-Brochterbeck G; Wiltfang J; Frölich L
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1267-8. PubMed ID: 18033678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy.
    Hriso E; Kuhn T; Masdeu JC; Grundman M
    Am J Psychiatry; 1991 Nov; 148(11):1558-61. PubMed ID: 1681751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone as an adjunct therapy for post-traumatic stress disorder.
    Krashin D; Oates EW
    Mil Med; 1999 Aug; 164(8):605-6. PubMed ID: 10459276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.